203 related articles for article (PubMed ID: 14572136)
1. Metachromatic leukodystrophy: recent research developments.
Gieselmann V
J Child Neurol; 2003 Sep; 18(9):591-4. PubMed ID: 14572136
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy in metachromatic leukodystrophy.
Sevin C; Cartier-Lacave N; Aubourg P
Int J Clin Pharmacol Ther; 2009; 47 Suppl 1():S128-31. PubMed ID: 20040324
[TBL] [Abstract][Full Text] [Related]
3. Increasing sulfatide synthesis in myelin-forming cells of arylsulfatase A-deficient mice causes demyelination and neurological symptoms reminiscent of human metachromatic leukodystrophy.
Ramakrishnan H; Hedayati KK; Lüllmann-Rauch R; Wessig C; Fewou SN; Maier H; Goebel HH; Gieselmann V; Eckhardt M
J Neurosci; 2007 Aug; 27(35):9482-90. PubMed ID: 17728461
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow stem cell gene therapy of arylsulfatase A-deficient mice, using an arylsulfatase A mutant that is hypersecreted from retrovirally transduced donor-type cells.
Matzner U; Schestag F; Hartmann D; Lüllmann-Rauch R; D'Hooge R; De Deyn PP; Gieselmann V
Hum Gene Ther; 2001 Jun; 12(9):1021-33. PubMed ID: 11399225
[TBL] [Abstract][Full Text] [Related]
5. Arylsulfatase A Overexpressing Human iPSC-derived Neural Cells Reduce CNS Sulfatide Storage in a Mouse Model of Metachromatic Leukodystrophy.
Doerr J; Böckenhoff A; Ewald B; Ladewig J; Eckhardt M; Gieselmann V; Matzner U; Brüstle O; Koch P
Mol Ther; 2015 Sep; 23(9):1519-31. PubMed ID: 26061647
[TBL] [Abstract][Full Text] [Related]
6. Genetics of metachromatic leukodystrophy.
Gieselmann V; Kreysing J; von Figura K
Gene Ther; 1994; 1 Suppl 1():S87. PubMed ID: 8542433
[TBL] [Abstract][Full Text] [Related]
7. Coexpression of formylglycine-generating enzyme is essential for synthesis and secretion of functional arylsulfatase A in a mouse model of metachromatic leukodystrophy.
Takakusaki Y; Hisayasu S; Hirai Y; Shimada T
Hum Gene Ther; 2005 Aug; 16(8):929-36. PubMed ID: 16076251
[TBL] [Abstract][Full Text] [Related]
8. Specific downregulation and mistargeting of the lipid raft-associated protein MAL in a glycolipid storage disorder.
Saravanan K; Schaeren-Wiemers N; Klein D; Sandhoff R; Schwarz A; Yaghootfam A; Gieselmann V; Franken S
Neurobiol Dis; 2004 Jul; 16(2):396-406. PubMed ID: 15193296
[TBL] [Abstract][Full Text] [Related]
9. Metachromatic leukodystrophy: molecular genetics and an animal model.
Gieselmann V; Matzner U; Hess B; Lüllmann-Rauch R; Coenen R; Hartmann D; D'Hooge R; DeDeyn P; Nagels G
J Inherit Metab Dis; 1998 Aug; 21(5):564-74. PubMed ID: 9728336
[TBL] [Abstract][Full Text] [Related]
10. Enzyme replacement improves nervous system pathology and function in a mouse model for metachromatic leukodystrophy.
Matzner U; Herbst E; Hedayati KK; Lüllmann-Rauch R; Wessig C; Schröder S; Eistrup C; Möller C; Fogh J; Gieselmann V
Hum Mol Genet; 2005 May; 14(9):1139-52. PubMed ID: 15772092
[TBL] [Abstract][Full Text] [Related]
11. Phenotype of arylsulfatase A-deficient mice: relationship to human metachromatic leukodystrophy.
Hess B; Saftig P; Hartmann D; Coenen R; Lüllmann-Rauch R; Goebel HH; Evers M; von Figura K; D'Hooge R; Nagels G; De Deyn P; Peters C; Gieselmann V
Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14821-6. PubMed ID: 8962139
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow stem cell-based gene transfer in a mouse model for metachromatic leukodystrophy: effects on visceral and nervous system disease manifestations.
Matzner U; Hartmann D; Lüllmann-Rauch R; Coenen R; Rothert F; Månsson JE; Fredman P; D'Hooge R; De Deyn PP; Gieselmann V
Gene Ther; 2002 Jan; 9(1):53-63. PubMed ID: 11850723
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of enzyme replacement therapy in an aggravated mouse model of metachromatic leukodystrophy declines with age.
Matthes F; Stroobants S; Gerlach D; Wohlenberg C; Wessig C; Fogh J; Gieselmann V; Eckhardt M; D'Hooge R; Matzner U
Hum Mol Genet; 2012 Jun; 21(11):2599-609. PubMed ID: 22388935
[TBL] [Abstract][Full Text] [Related]
14. Deletion of fatty acid amide hydrolase reduces lyso-sulfatide levels but exacerbates metachromatic leukodystrophy in mice.
Yaghootfam C; Gehrig B; Sylvester M; Gieselmann V; Matzner U
J Biol Chem; 2021 Sep; 297(3):101064. PubMed ID: 34375644
[TBL] [Abstract][Full Text] [Related]
15. Developing therapeutic approaches for metachromatic leukodystrophy.
Patil SA; Maegawa GH
Drug Des Devel Ther; 2013; 7():729-45. PubMed ID: 23966770
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy for metachromatic leukodystrophy.
Rosenberg JB; Kaminsky SM; Aubourg P; Crystal RG; Sondhi D
J Neurosci Res; 2016 Nov; 94(11):1169-79. PubMed ID: 27638601
[TBL] [Abstract][Full Text] [Related]
17. Saposin B-dependent reconstitution of arylsulfatase A activity in vitro and in cell culture models of metachromatic leukodystrophy.
Matzner U; Breiden B; Schwarzmann G; Yaghootfam A; Fluharty AL; Hasilik A; Sandhoff K; Gieselmann V
J Biol Chem; 2009 Apr; 284(14):9372-81. PubMed ID: 19224915
[TBL] [Abstract][Full Text] [Related]
18. Lysosomal leukodystrophies: Krabbe disease and metachromatic leukodystrophy.
Kohlschütter A
Handb Clin Neurol; 2013; 113():1611-8. PubMed ID: 23622382
[TBL] [Abstract][Full Text] [Related]
19. Metachromatic leukodystrophy: consequences of sulphatide accumulation.
Gieselmann V; Franken S; Klein D; Mansson JE; Sandhoff R; Lüllmann Rauch R; Hartmann D; Saravanan VP; De Deyn PP; D'Hooge R; Van Der Linden AM; Schaeren-Wiemers N
Acta Paediatr Suppl; 2003 Dec; 92(443):74-9; discussion 45. PubMed ID: 14989469
[TBL] [Abstract][Full Text] [Related]
20. Three novel mutant arylsulfatase A alleles causing metachromatic leukodystrophy.
Yaghootfam A; Baumann N; Schwarz A; Gieselmann V
Neurochem Res; 2004 May; 29(5):933-42. PubMed ID: 15139291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
